Retroviral targeted delivery

Gene Therapy

Volumn 3, Issue 12, 1996, Pages 1069-1073

  Schnierle, B S ^a   Groner, B ^a  

^a TUMOR BIOLOGY CENTER   (Germany)

Author keywords

Envelope; Gene therapy; Retrovirus; Targeting

Indexed keywords

CELL SURFACE RECEPTOR; HYBRID PROTEIN; VIRUS ENVELOPE PROTEIN; VIRUS RECEPTOR;

ENVELOPE GENE; EXPRESSION VECTOR; GENE TARGETING; NONHUMAN; PRIORITY JOURNAL; RETROVIRUS; SHORT SURVEY; VIRUS CELL INTERACTION; VIRUS INFECTION;

GENE PRODUCTS, ENV; GENE THERAPY; GENETIC VECTORS; HUMANS; IMMUNOGLOBULIN FRAGMENTS; LEUKEMIA VIRUS, MURINE; RECEPTORS, VIRUS; RETROVIRIDAE; RETROVIRIDAE INFECTIONS;

EID: 0030460250     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (29)

1. Salmons B, Günzburg WH. Targeting of retroviral vectors for gene therapy. Hum Gene Ther 1993; 4: 129-141.
2. Paulus W et al. Self-contained, tetracycline-regulated retroviral vector system for gene delivery to mammalian cells. J Virol 1996; 70: 62-67.
3. Oldfield EH et al. Gene therapy for the treatment of brain tumors using intra-tumoral transduction with the thymidine kinase gene and intravenous ganciclovir. Hum Gene Ther 1993; 4: 39-69.
4. Weiss RA, Tailor CS. Retrovirus receptors. Cell 1995; 82: 531-533.
5. Albritton LM, Tseng L, Scadden D, Cunningham JM. A putative murine ecotropic retrovirus receptor gene encodes a multiple membrane-spanning protein and confers susceptibility to virus infection. Cell 1989; 57: 659-666.
6. Miller DG, Edwards RH, Miller AD. Cloning of the cellular receptor for amphotropic murine retroviruses reveals homology to that for gibbon ape leukemia virus. Proc Natl Acad Sci USA 1994; 91: 78-82.
7. Yoshimoto T, Yoshimoto E, Meruelo D. Identification of amino acid residues critical for infection with ecotropic murine leukemia retrovirus. J Virol 1993; 67: 1310-1314.
8. Hunter E, Swanstrom R. Retrovirus envelope glycoproteins. Curr Top Microbiol Immunol 1990; 157: 187-253
9. Battini J-L, Heard J-M, Danos O. Receptor choice determinants in the envelope glycoproteins of amphotropic, xenotropic and polytropic murine leukemia virus. J Virol 1992; 66: 1468-1475.
10. Morgan R et al. Analysis of the functional and host range-determining regions of the murine ecotropic and amphotropic retrovirus envelope proteins. J Virol 1993; 67: 4712-4721.
11. Burns JC et al. Vesicular stomatitis virus G glycoprotein pseudotyped retroviral vectors: concentration to high titer and efficient gene transfer into mammalian and nonmammalian cells. Proc Natl Acad Sci USA 1993; 90: 8033-8037.
12. Dong J, Roth MG, Hunter E. A chimeric avian retrovirus containing the influenza virus hemagglutinin gene has an expanded host range. J Virol 1992; 66: 7374-7382.
13. Gray KD, Roth MJ Mutational analysis of the envelope gene of Moloney murine leukemia virus. J Virol 1993; 67: 3489-3496.
14. Russell SJ, Hawkins RE, Winter G. Retroviral vectors displaying functional antibody fragments. Nucleic Acids Res 1993; 21: 1081-1085.
15. Schnierle BS, Moritz D, Jeschke M, Groner B. Expression of chimeric envelope proteins in helper cell lines and integration into Moloney murine leukemia virus particles. Gene Therapy 1996, 3: 334-342.
16. Hakomori S. New directions in cancer therapy based on aberrant expression of glycosphingolipids: anti-adhesion and ortho-signaling therapy. Cancer Cells 1991; 3: 461-470.
17. Somia NV, Zoppe M, Verma IM. Generation of targeted retroviral vectors by using single-chain variable fragment: an approach to in vivo gene delivery. Proc Natl Acad Sci USA 1995; 92: 7570-7574.
18. Cosset F-L et al. Retroviral retargeting by envelopes expressing an N-terminal binding domain. J Virol 1995; 69: 6314-6322.
19. Jeschke M et al. Targeted inhibition of tumor cell growth by recombinant heregulin-toxin fusion proteins. Int J Cancer 1995; 60: 730-739.
20. Maoret J-J et al. Neurotensin receptor and its mRNA are expressed in many human colon cancer cell lines but not in normal colonic epithelium: binding studies and RT-PCR experiments. Biochem Biophys Res Commun 1994; 203: 465-471.
21. Biasi F. Urokinase and urokinase receptor: a paracrine/ autocrine system regulating cell migration and invasiveness. Bioessays 1993; 15: 105-111.
22. Janeway CA, Bottomly K. Signals and signs for lymphocyte responses. Cell 1994; 76: 275-285.
23. Kasahara N, Dozy AM, Kan YW. Tissue-specific targeting of retroviral vectors through ligand-receptor interaction. Science 1994; 266: 1373-1376.
24. Han X, Kasahara N, Kan YW. Ligand-directed retroviral targeting of human breast cancer cells. Proc Natl Acad Sci USA 1995; 92: 9747-9751.
25. Valsesia-Wittmann S et al. Improvement of retroviral retargeting by using amino acid spacers between an additional binding domain and the N terminus of Moloney murine leukemia virus SU. J Virol 1996; 70: 2059-2064.
26. Valsesia-Wittmann S et al. Modifications in the binding domain of avian retrovirus envelope protein to redirect the host range of retroviral vectors. J Virol 1994; 68: 4609-4619.
27. Chu TT-H, Martinez I, Sheary WC, Dornburg R. Cell targeting with retroviral vector particles containing antibody-envelope fusion proteins Gene Therapy 1994; 1: 292-299.
28. Chu TT-H, Dornburg R. Retroviral vector particles displaying the antigen-binding site of an antibody enable cell-type-specific gene transfer. J Virol 1995; 69: 2659-2663.
29. Cosset F-L et al. High-titer packaging cells producing recombinant retroviruses resistant to human serum. J Virol 1995; 69: 7430-7436.